Opportunity ID: 250914

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-14-089
Funding Opportunity Title: Alzheimer’s Disease Pilot Clinical Trials (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Feb 05, 2014
Last Updated Date: Oct 06, 2015
Original Closing Date for Applications: May 07, 2017
Current Closing Date for Applications: Oct 06, 2015
Archive Date: Nov 06, 2015
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
County governments
City or township governments
For profit organizations other than small businesses
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
Private institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The objective of the Alzheimers Disease Pilot Clinical Trials initiative is to enable the clinical testing (Phase I and II) of promising pharmacological and non-pharmacological interventions in individuals across the Alzheimer’s disease (AD) spectrum from pre-symptomatic to more severe stages of disease, as well as to stimulate studies to enhance trial design and methods.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-14-089.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date
Modified the close date field, in accordance with PAR-16-365. Oct 06, 2015
Oct 06, 2015

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-14-089
Funding Opportunity Title: Alzheimer’s Disease Pilot Clinical Trials (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Feb 05, 2014
Last Updated Date: Oct 06, 2015
Original Closing Date for Applications: May 07, 2017
Current Closing Date for Applications: Oct 06, 2015
Archive Date: Nov 06, 2015
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
County governments
City or township governments
For profit organizations other than small businesses
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
Private institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The objective of the Alzheimers Disease Pilot Clinical Trials initiative is to enable the clinical testing (Phase I and II) of promising pharmacological and non-pharmacological interventions in individuals across the Alzheimer’s disease (AD) spectrum from pre-symptomatic to more severe stages of disease, as well as to stimulate studies to enhance trial design and methods.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-14-089.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-14-089
Funding Opportunity Title: Alzheimer’s Disease Pilot Clinical Trials (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Oct 06, 2015
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 07, 2017
Archive Date: Jun 07, 2017
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: For profit organizations other than small businesses
Special district governments
Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public housing authorities/Indian housing authorities
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
State governments
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
County governments
City or township governments
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The objective of the Alzheimers Disease Pilot Clinical Trials initiative is to enable the clinical testing (Phase I and II) of promising pharmacological and non-pharmacological interventions in individuals across the Alzheimer’s disease (AD) spectrum from pre-symptomatic to more severe stages of disease, as well as to stimulate studies to enhance trial design and methods.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-14-089.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.866 FORMS-C Forms-C PKG00192551 May 05, 2014 Oct 07, 2015 View

Package 1

Mandatory forms

250914 RR_SF424_2_0-2.0.pdf

250914 PHS398_ResearchPlan_2_0-2.0.pdf

250914 PHS398_CoverPageSupplement_2_0-2.0.pdf

250914 RR_KeyPersonExpanded_2_0-2.0.pdf

250914 RR_OtherProjectInfo_1_3-1.3.pdf

250914 PerformanceSite_2_0-2.0.pdf

Optional forms

250914 RR_SubawardBudget30_1_3-1.3.pdf

250914 PlannedReport-1.0.pdf

250914 PHS398_CumulativeInclusionReport-1.0.pdf

250914 PHS398_ModularBudget_1_2-1.2.pdf

250914 RR_Budget_1_3-1.3.pdf

2025-07-09T08:43:03-05:00

Share This Post, Choose Your Platform!

About the Author: